Patented biomarker for cardiac injury. 

Patented biomarker for cardiac injury. 

Determinants of cMyC in the General Population

In the general population, circulating cMyC concentrations are associated with cardiovascular risk factors, reflect left ventricular remodelling, including focal myocardial fibrosis, and systolic and diastolic dysfunction independently of traditional risk factors.

cMyC (Cardiac Myosin-binding protein C)
cMyC (Cardiac Myosin-binding protein C)